Literature DB >> 22350588

Erythropoietin reverts cognitive impairment and alters the oxidative parameters and energetic metabolism in sepsis animal model.

Clarissa M Comim1, Omar J Cassol, Igor Abreu, Thais Moraz, Larissa S Constantino, Francieli Vuolo, Letícia S Galant, Natália de Rochi, Meline O Dos Santos Morais, Giselli Scaini, Tatiana Barichello, Emílio L Streck, João Quevedo, Felipe Dal-Pizzol.   

Abstract

Sepsis is characterized by systemic biochemical alterations including the central nervous system in the early times and cognitive impairment at later times after sepsis induction in the animal model. Recent studies have shown that, besides its hematological activity, erythropoietin (EPO) has cytoprotective effects on various cells and tissues. In order to corroborate elucidating the effects of alternative drugs for sepsis treatment, we evaluated the effects of both acute and chronic EPO treatment on oxidative stress and energetic metabolism in the hippocampus, and cognitive impairment, respectively, after sepsis induction by cecal ligation and perforation (CLP). To this aim, male Wistar rats underwent CLP with "basic support" or sham operation. In the acute treatment, EPO was administered once immediately after CLP induction. The rats were then killed after 6 and 24 h, and the hippocampus was removed for analysis of oxidative stress and energetic metabolism, respectively. Regarding the chronic treatment, EPO was administered once daily until the 4th day after induction. Aversive memory was tested on the 10th day after surgery. It was observed that the acute use of EPO (a single dose) alters the oxidative parameters and energetic metabolism. Chronic use (4 days) reversed cognitive impairment in the sepsis animal model. Mortality rates were attenuated only during chronic treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22350588     DOI: 10.1007/s00702-012-0774-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  62 in total

Review 1.  Erythropoietin: structure, control of production, and function.

Authors:  W Jelkmann
Journal:  Physiol Rev       Date:  1992-04       Impact factor: 37.312

2.  The encephalopathy associated with septic illness.

Authors:  G B Young; C F Bolton; T W Austin; Y M Archibald; J Gonder; G A Wells
Journal:  Clin Invest Med       Date:  1990-12       Impact factor: 0.825

3.  Long-term cognitive impairment and functional disability among survivors of severe sepsis.

Authors:  Theodore J Iwashyna; E Wesley Ely; Dylan M Smith; Kenneth M Langa
Journal:  JAMA       Date:  2010-10-27       Impact factor: 56.272

4.  Cytochrome c oxidase assay in minute amounts of human skeletal muscle using single wavelength spectrophotometers.

Authors:  O Miró; F Cardellach; A Barrientos; J Casademont; A Rötig; P Rustin
Journal:  J Neurosci Methods       Date:  1998-03-13       Impact factor: 2.390

5.  Oxidative variables in the rat brain after sepsis induced by cecal ligation and perforation.

Authors:  Tatiana Barichello; Jucélia J Fortunato; Angeles M Vitali; Gustavo Feier; Adalisa Reinke; José Cláudio F Moreira; João Quevedo; Felipe Dal-Pizzol
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

6.  The effect of erythropoietin on interleukin-1beta mediated increase in nitric oxide synthesis in vascular smooth muscle cells.

Authors:  T Akimoto; E Kusano; S Muto; N Fujita; K Okada; T Saito; N Komatsu; S Ono; S Ebata; Y Ando; S Homma; Y Asano
Journal:  J Hypertens       Date:  1999-09       Impact factor: 4.844

Review 7.  Experimental models of pathologic oxygen supply dependency.

Authors:  S M Cain; S E Curtis
Journal:  Crit Care Med       Date:  1991-05       Impact factor: 7.598

8.  Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport.

Authors:  A Cassina; R Radi
Journal:  Arch Biochem Biophys       Date:  1996-04-15       Impact factor: 4.013

Review 9.  The septic brain.

Authors:  Emilio L Streck; Clarissa M Comim; Tatiana Barichello; João Quevedo
Journal:  Neurochem Res       Date:  2008-05-07       Impact factor: 3.996

10.  Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.

Authors:  Julia Bohlius; Kurt Schmidlin; Corinne Brillant; Guido Schwarzer; Sven Trelle; Jerome Seidenfeld; Marcel Zwahlen; Michael Clarke; Olaf Weingart; Sabine Kluge; Margaret Piper; Dirk Rades; David P Steensma; Benjamin Djulbegovic; Martin F Fey; Isabelle Ray-Coquard; Mitchell Machtay; Volker Moebus; Gillian Thomas; Michael Untch; Martin Schumacher; Matthias Egger; Andreas Engert
Journal:  Lancet       Date:  2009-05-02       Impact factor: 79.321

View more
  5 in total

Review 1.  Nitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines.

Authors:  Robert A Floyd; Hugo C Castro Faria Neto; Guy A Zimmerman; Kenneth Hensley; Rheal A Towner
Journal:  Free Radic Biol Med       Date:  2013-02-16       Impact factor: 7.376

Review 2.  Evidence That Erythropoietin Modulates Neuroinflammation through Differential Action on Neurons, Astrocytes, and Microglia.

Authors:  Wesley S Bond; Tonia S Rex
Journal:  Front Immunol       Date:  2014-10-22       Impact factor: 7.561

Review 3.  Is There a Role for Hematopoietic Growth Factors During Sepsis?

Authors:  Benjamin G Chousterman; Marine Arnaud
Journal:  Front Immunol       Date:  2018-06-21       Impact factor: 7.561

Review 4.  Systemic Response to Infection Induces Long-Term Cognitive Decline: Neuroinflammation and Oxidative Stress as Therapeutical Targets.

Authors:  Patricia Alves Reis; Hugo Caire Castro-Faria-Neto
Journal:  Front Neurosci       Date:  2022-02-18       Impact factor: 4.677

5.  The Surviving Sepsis Campaign: Basic/Translational Science Research Priorities.

Authors:  Clifford S Deutschman; Judith Hellman; Ricard Ferrer Roca; Daniel De Backer; Craig M Coopersmith
Journal:  Crit Care Med       Date:  2020-08       Impact factor: 9.296

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.